2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow Enterobacteriaceae Infections: new trials by email Literature Review of Enterobacteriaceae Infections trials Research Report on Enterobacteriaceae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area Placebo, Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral enterotoxigenic Escherichia coli (ETEC) Vaccine - Gastroenteritis Escherichia Coli, Immunisation | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 75 | 2019-03-10 | 2025-05-21 |
| Enteroaggregative E.Coli (EAEC) Levofloxacin, Placebo, Enteroaggregative E. coli (EAEC) - Escherichia Coli Infections | Phase 1 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 5 | 2008-02-01 | 2016-12-26 |
Escherichia coli Infections (2) · Diarrhea (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Negative Bacterial Infections (2) · Infections (2) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Levofloxacin (1) · Vaccines (1) · heat stable toxin (E coli) (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (2) · Bangladesh (1)